Monopar Therapeutics Inc. buy Midas
Start price
24.10.20
/
50%
€4.00
Target price
04.11.21
-
Performance (%)
37.50%
End price
26.01.21
€5.50
Summary
This prediction ended on 26.01.21 with a price of €5.50. With a performance of 37.50% the BUY prediction by Midas was a big success. Midas has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Monopar Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 3,90 % | 2,67 % | 5,69 % | 53,46 % |
| iShares Nasdaq 100 | -2,60 % | -7,93 % | 19,50 % | 72,28 % |
| iShares Nikkei 225® | -0,54 % | -9,75 % | 46,05 % | 63,08 % |
| iShares S&P 500 | -0,88 % | -1,49 % | 16,91 % | 60,40 % |
Comments by Midas for this prediction
In the thread Monopar Therapeutics Inc. diskutieren
Buy Monopar Therapeutics Inc.